A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL
- Status
- COMPLETED
- Phase
- PHASE2
CLL Therapy Approaches in Russia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
- Status
- COMPLETED
- Phase
- N/A
VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA
- Status
- COMPLETED
- Phase
- N/A
Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Dapagliflozin Post Marketing Surveillance in HF and CKD
- Status
- COMPLETED
- Phase
- N/A
EU Secondary Data Post-Authorisation Safety Study of AZD1222
- Status
- COMPLETED
- Phase
- N/A
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A